Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Clinical Trial
100%
Neutrophil Chemotaxis
100%
Solution and Solubility
100%
Cell Junction
100%
Animal Model
100%
Hepatocyte Growth Factor
100%
Syndecan 1
100%
Translating (Language)
100%
Proinflammatory Cytokine
100%
Tissue Regeneration
100%
Angiopoietin 1
100%
Animal Experiment
100%
Surfactant
100%
Optimal Drug Dose
100%
Mir-126
100%
Fibrinogen
100%
Programmed Cell Death
100%
Macrophage Polarization
100%
Keyphrases
Lung Injury
100%
Potential Therapy
100%
COVID-19
100%
Extracellular Vesicles
100%
Acute Respiratory Distress Syndrome
50%
Severe COVID-19 Infection
33%
Inflammatory Cytokines
16%
Apoptosis
16%
Regenerative Medicine
16%
Fibrosis
16%
Stem Cells
16%
Regeneration
16%
Survivors
16%
Cargo
16%
Route of Administration
16%
Attenuation
16%
Syndecan-1
16%
Multiple Pathways
16%
Large Animal Model
16%
Hepatocyte Growth Factor
16%
Pulmonary Disease
16%
Human Trials
16%
Systematic Literature Review
16%
Fibrin
16%
Therapeutic Use
16%
Neutrophil Infiltration
16%
Vascular Permeability
16%
Pulmonary Fibrosis
16%
Tissue Regeneration
16%
Human Patients
16%
Inflammation Regulation
16%
Angiopoietin
16%
Search Strategy
16%
COVID-19 Patients
16%
M2 Macrophage Polarization
16%
Endothelial Junctions
16%
Support Measures
16%
Optimal Dose
16%
Alveolar Epithelium
16%
Good Manufacturing Practice
16%
COVID-19 Related
16%
Lung Injury Model
16%
MiR-126
16%
Surfactant Production
16%
Large Animal Study
16%
Intercellular Junction Proteins
16%
Bilateral Pneumonia
16%
Extracellular Vesicle Delivery
16%
Medicine and Dentistry
Systematic Review
100%
COVID-19
100%
Acute Respiratory Distress Syndrome
60%
Infection
40%
Inflammatory Cytokine
20%
Clinical Trial
20%
Medicine
20%
Endothelial Cell
20%
Fibrosis
20%
Cell Junction
20%
Programmed Cell Death
20%
Syndecan 1
20%
Fibrinogen
20%
Optimal Drug Dose
20%
Neutrophil Chemotaxis
20%
Idiopathic Interstitial Pneumonia
20%
Translating (Language)
20%
Pulmonary Fibrosis
20%
Stem Cell
20%
Tissue Regeneration
20%
Angiopoietin 1
20%
Macrophage Polarization
20%
M2 Macrophages
20%
Scatter Factor
20%
Alveolar Epithelium
20%
Drug Administration Route
20%
microRNA 126
20%
Surfactant
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
100%
Infection
66%
Clinical Trial
33%
Cytokine
33%
Inflammation
33%
Fibrosis
33%
Scatter Factor
33%
Surfactant
33%
Fibrinogen
33%
Lung Fibrosis
33%
Interstitial Pneumonia
33%
Good Manufacturing Practice
33%
Angiopoietin 1
33%
microRNA 126
33%
Syndecan 1
33%